|
Progress in RNA-Based TherapeuticsPublished by: Decision Resources Published: Aug. 4, 2005 - 26 Pages The price of this report has been reduced due to its age. The original price was $1,900 for PDF E-mail From Publisher.Table of Contents
AbstractThe field of nucleic acid-based therapeutics ranges from gene therapy technologies for replacing defective or missing genes to gene-blocking or gene-silencing technologies for preventing the expression of deleterious genes. RNA-based therapeutics are a relatively new addition to the field, and we focus on three such technologies in this report: antisense oligonucleotides, RNA interference, and microRNAs. These three technologies are particularly dynamic; antisense, for example, has suffered a series of negative clinical trial results that may have stalled its progress, and RNA interference has been hailed as a revolutionary breakthrough and has generated interest from more than 100 companies. In this report, we describe these three RNA-based technologies, review recent progress in RNA-based drug discovery and development, and profile the activities of companies in the field.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||